This webinar covers how to form a clinical pharmacology strategy for your drug development program. All drug programs must address clinical pharmacology to enable an approvable NDA or BLA. Understanding basic clinical pharmacology strategies such as which investigations you need or don’t need and which investigations to do now versus later is important for your program’s overall strategy.
At the end of this webinar attendees should have a better understanding of:
- Approaches to designing a clinical pharmacology program
- How to build a clinical pharmacology program
- Common mistakes and lessons learned
- Hypothetical examples of clinical pharmacology programs
Meet the Speaker
Geoffrey Banks, PhD
Chief Executive Officer
Dr. Banks founded Nuventra in 2008 and has led the company since then as both CEO and as a principal consultant. He has over 20 years of extensive experience in large pharma, biotechnology, and specialty pharma, and an established track record of clinical, regulatory, and entrepreneurial success. Dr. Banks has served as a clinical pharmacology consultant and corporate R&D advisor to over 300 companies that range from venture-backed startup biotech companies through large multinational pharmaceutical companies.